Black Friday saleUp to 70% OFF
MARKSANS PHARMA LTD.MARKSANS PHARMA LTD.MARKSANS PHARMA LTD.

MARKSANS PHARMA LTD.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

MARKSANS chart


Full chart

MARKSANS upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪156.59 B‬ INR
Dividend yield (indicated)
0.17%
Price to earnings Ratio (TTM)
43.85
Basic EPS (TTM)
7.65 INR
Net income (FY)
‪3.14 B‬ INR
Revenue (FY)
‪21.76 B‬ INR
Shares float
‪204.32 M‬
Beta (1Y)
1.51

Employees


Employees (FY)
‪1.42 K‬
Change (1Y)
+18 +1.29%
Revenue / Employee (1Y)
‪184.01 K‬ INR
Net income / Employee (1Y)
‪26.52 K‬ INR

About MARKSANS PHARMA LTD


Sector
Health Technology
CEO
Mark Bosco Saldanha
Headquarters
Mumbai
Website
marksanspharma.com
Founded
1992
ISIN
INE750C01026
FIGI
BBG000D7VQ16
Marksans Pharma Ltd. engages in the research, manufacture, marketing, and sale of pharmaceutical formulations. Its product portfolio includes tablets, hard capsules, soft gelatin capsules, oral liquids, and ointments. It operates through the following geographical segments: US and North America, Europe and UK, Australia and New Zealand, India, and Rest of World. The company was founded by Mark Bosco Saldanha on April 16, 1992 and is headquartered in Mumbai, India.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

MARKSANS news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of MARKSANS is 342.75 INR — it has increased by 2.05% in the past 24 hours. Watch MARKSANS PHARMA LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange MARKSANS PHARMA LTD. stocks are traded under the ticker MARKSANS.
MARKSANS stock has risen by 10.05% compared to the previous week, the month change is a 24.86% rise, over the last year MARKSANS PHARMA LTD. has showed a 114.35% increase.
We've gathered analysts' opinions on MARKSANS PHARMA LTD. future price: according to them, MARKSANS price has a max estimate of 376.00 INR and a min estimate of 350.00 INR. Watch MARKSANS chart and read a more detailed MARKSANS PHARMA LTD. stock forecast: see what analysts think of MARKSANS PHARMA LTD. and suggest that you do with its stocks.
MARKSANS reached its all-time high on Sep 20, 2024 with the price of 328.35 INR, and its all-time low was 1.25 INR and was reached on May 18, 2012. View more price dynamics on MARKSANS chart.
See other stocks reaching their highest and lowest prices.
MARKSANS stock is 6.35% volatile and has beta coefficient of 1.51. Track MARKSANS PHARMA LTD. stock price on the chart and check out the list of the most volatile stocks — is MARKSANS PHARMA LTD. there?
Today MARKSANS PHARMA LTD. has the market capitalization of ‪152.19 B‬, it has decreased by −0.10% over the last week.
Yes, you can track MARKSANS PHARMA LTD. financials in yearly and quarterly reports right on TradingView.
MARKSANS PHARMA LTD. is going to release the next earnings report on Feb 7, 2025. Keep track of upcoming events with our Earnings Calendar.
MARKSANS net income for the last quarter is ‪967.16 M‬ INR, while the quarter before that showed ‪887.52 M‬ INR of net income which accounts for 8.97% change. Track more MARKSANS PHARMA LTD. financial stats to get the full picture.
Yes, MARKSANS dividends are paid annually. The last dividend per share was 0.60 INR. As of today, Dividend Yield (TTM)% is 0.18%. Tracking MARKSANS PHARMA LTD. dividends might help you take more informed decisions.
MARKSANS PHARMA LTD. dividend yield was 0.40% in 2023, and payout ratio reached 8.67%. The year before the numbers were 0.71% and 7.80% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 29, 2024, the company has ‪1.42 K‬ employees. See our rating of the largest employees — is MARKSANS PHARMA LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MARKSANS PHARMA LTD. EBITDA is ‪5.07 B‬ INR, and current EBITDA margin is 21.16%. See more stats in MARKSANS PHARMA LTD. financial statements.
Like other stocks, MARKSANS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MARKSANS PHARMA LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MARKSANS PHARMA LTD. technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MARKSANS PHARMA LTD. stock shows the strong buy signal. See more of MARKSANS PHARMA LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.